Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phenol versus botulinum toxin A for lower limb spasticity
IRCT20170826035914N2Phase 3Completed
- Sponsor
- Shiraz University of Medical Sciences
- Start
- Mar 2017
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in Muscle spasm comparing Phenol injection with Botulinum toxin A injection (2 arms). Primary endpoint: Improvement of spasticity according to the Ashworth criteria. Started Mar 2017; status: completed.
02
Drugs
phenolbotulinum toxin type A
03
Conditions
Muscle spasm
Beyond the preview
Go deeper on IRCT20170826035914N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20170826035914N2.